UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.69 -0.94 (-1.14%) GOLD FUTURES
2,307.30 -50.40 (-2.14%) DOW
37,990.53 -395.56 (-1.03%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
Neurocrine Biosciences, Inc. (0K6R.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:38PM BST
| Previous close | 138.95 |
| Open | 138.07 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 137.97 - 140.34 |
| 52-week range | 89.66 - 143.27 |
| Volume | |
| Avg. volume | 1,189 |
| Market cap | 136.065M |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | 1.89 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Curious about Neurocrine (NBIX) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Neurocrine (NBIX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
- Investor's Business Daily
Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?
Top-notch biotech stock Neurocrine surged Tuesday after analysts suggested the company's depression treatment could rival ketamine.
- Zacks
Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
Neurocrine (NBIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.